Data from European Association of Urology (EAU) - Curated by EPG Health - Last updated 11 July 2019

Status

live

Latest update

01-Mar-19

The European Association of Urology (EAU) Guidelines Group for Prostate Cancer have prepared this guidelines document to assist medical professionals assess the evidence-based management of prostate cancer (PCa). The multidisciplinary guidelines panel includes urologists, radiation oncologists, a medical oncologist, a radiologist and a pathologist.

Read full guideline

Comments

You will need to login, to leave a comment.

epgonline.org is not monitored for collection of adverse event reports. Any adverse events should be reported to your national reporting agency and/or the manufacturer.

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Fluid Management

Fluid Management

Are you up-to-date with the latest evidence of effective procedures for fluid management?

+ 2 more

Hereditary ATTR amyloidosis

Hereditary ATTR amyloidosis

Explore the pathophysiology, epidemiology and multi-system symptoms associated with hereditary ATTR amyloidosis, as well as how to achieve an early and accurate diagnosis.

Chronic Lymphocytic Leukaemia (CLL)

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

+ 1 more

Load more

Related Content

News

PROSPER trial protocol of Xtandi (enzalutamide) in patients with non-metastatic castration-resistant prostate cancer is amended.- Astellas and Pfizer

Astellas Pharma Inc. and Pfizer Inc.announced the amendment of the protocol for the registrational PROSPER trial, a multi-national, randomized, double-blind,...

Added 2 years ago

Phase III LATITUDE clinical trial shows Zytiga (abiraterone acetate) plus prednisone shows impressive improvement in survival in metastatic prostate cancer- Janssen R&D

Janssen Research & Development announced data from the pivotal phase III LATITUDE clinical trial, which showed Zytiga (abiraterone acetate) plus...

Added 2 years ago

Prolaris test accurately predicts the 10-year risk of metastases in men treated for prostate cancer.- Myriad Genetics Inc.

- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, announced new data demonstrating the utility of the...

Added 2 years ago

Myovant initiates Phase III HERO trial of relugolix to treat advanced prostate cancer-

Myovant Sciences announced it has initiated a Phase III clinical trial, HERO , to evaluate the safety and efficacy of...

Added 2 years ago

Phase III data on FP 001 (leuprolide mesylate injectable suspension) in prostate cancer- Foresee Pharmaceuticals

Foresee Pharmaceuticals has announced the top-line result of FP 001 (leuprolide mesylate injectable suspension) 50mg phase III clinical trial, an...

Added 2 years ago

Load more

View all 11448 News items
Journal articles

Diagnostic properties of total and free prostate-specific antigen to predict overall and clinically significant prostate cancer among men with low testosterone and prior negative biopsy.

Objective: To evaluate whether total serum PSA, free-PSA ratio and PSA density have similar diagnostic properties for detecting prostate cancer (PCa) and clinically-significant (cs) PCa in men with normal testosterone compared...

Added 25 days ago

Role of Androgen Receptor in Prostate Cancer: A Review.

This review focuses on the functions of AR in prostate cancer and the development of CRPC and promising new agents against CRPC.

Added 25 days ago

Increased expression of miR-153 predicts poor prognosis for patients with prostate cancer.

Deregulation of miR-153 has recently been observed in several common human cancer, while miR-153 serves an oncogene or tumor suppressive role in different cancer types. Previously, miR-153 has been identified to be overexpressed in...

Added 25 days ago

Prostate radiotherapy in newly diagnosed metastatic prostate cancer.

Purpose of review: The aim of this article is to review the role of prostate radiotherapy in the multimodal management of newly diagnosed metastatic hormone naïve prostate cancer.

Added 25 days ago

Prostate cancer in young men: An emerging young adult and older adolescent challenge.

Background: Recent observations suggest that prostate cancer is an increasing disease among older adolescents and young adults.

Added 2 months ago

Load more

View all 14100 Journal articles items
Clinical trials

Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance. (PCM301)

The aims of this study are:
- to assess the impact of TOOKAD® Soluble-Vascular Targeted Photodynamic Therapy (VTP) on the rate of absence of definite cancer using patients on active surveillance as a comparison...

Added 9 years ago

Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

The purpose of this study is to assess the efficacy and safety of the combination of pembrolizumab (MK-3475) and enzalutamide in the treatment of men with metastatic castration-resistant prostate cancer (mCRPC) who have not received...

Added 25 days ago

A Study of Apalutamide in Participants With High‑Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy (PROTEUS)

The purpose of this study is to determine if treatment with androgen deprivation therapy (ADT) plus apalutamide before and after radical prostatectomy in participants with high-risk localized or locally advanced prostate cancer results...

Added 25 days ago

Study of Nivolumab Plus Ipilimumab, Ipilimumab or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650)

The purpose of this study is to determine whether Nivolumab plus Ipilimumab has preliminary evidence of safety and effectiveness in the treatment of participants with metastatic castration-resistant prostate cancer who have progressed after...

Added 25 days ago

A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutamide from the subjects participation in an enzalutamide clinical study sponsored by Astellas or...

Added 25 days ago

Load more

View all 7796 Clinical trials items